Contact this trialFirst, we need to learn more about you.
Wake-promoting Agent
Solriamfetol for Multiple Sclerosis Fatigue
Recruiting0 awardsPhase 2
Baltimore, Maryland
"This trial aims to study fatigue in Multiple Sclerosis patients. Current treatments are not very effective, so the study will test a new medication on patients with excessive daytime sleepiness. The study will be double
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service